$0.00
28.57% yesterday
Nasdaq, Nov 25, 08:10 pm CET
ISIN
US88362L1008
Symbol
THMO

ThermoGenesis Holdings Inc Stock price

$0.00
-0.01 96.67% 1M
-0.62 99.92% 6M
-0.60 99.92% YTD
-0.87 99.94% 1Y
-56.70 100.00% 3Y
-141.30 100.00% 5Y
-9,810.00 100.00% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.00 28.57%
ISIN
US88362L1008
Symbol
THMO
Sector

Key metrics

Market capitalization $10.00k
Enterprise Value $4.34m
P/E (TTM) P/E ratio 0.00
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.45
P/S ratio (TTM) P/S ratio 0.00
P/B ratio (TTM) P/B ratio 0.00
Revenue growth (TTM) Revenue growth -7.53%
Revenue (TTM) Revenue $9.61m
EBIT (operating result TTM) EBIT $-6.09m
Free Cash Flow (TTM) Free Cash Flow $-4.59m
Cash position $1.18m
EPS (TTM) EPS $-4.75
P/S forward 0.13
EV/Sales forward 0.34
Short interest 0.30%
Show more

Is ThermoGenesis Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

ThermoGenesis Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast ThermoGenesis Holdings Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast ThermoGenesis Holdings Inc:

Buy
100%

Financial data from ThermoGenesis Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
9.61 9.61
8% 8%
100%
- Direct Costs 7.58 7.58
1% 1%
79%
2.03 2.03
30% 30%
21%
- Selling and Administrative Expenses 5.71 5.71
10% 10%
59%
- Research and Development Expense 1.19 1.19
21% 21%
12%
-4.87 -4.87
2% 2%
-51%
- Depreciation and Amortization 1.21 1.21
16% 16%
13%
EBIT (Operating Income) EBIT -6.09 -6.09
1% 1%
-63%
Net Profit -15 -15
2% 2%
-153%

In millions USD.

Don't miss a Thing! We will send you all news about ThermoGenesis Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ThermoGenesis Holdings Inc Stock News

Negative
InvestorPlace
6 months ago
ThermoGenesis (NASDAQ: THMO ) stock is taking a beating on Wednesday after the company announced an update on its listing compliance. According to a ThermoGenesis filing, it has received another delisting notice from the Nasdaq Exchange.

Company Profile

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Head office United States
CEO Xiao Xu
Employees 25
Founded 1986
Website www.thermogenesis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today